Category: Healthcare and Pharmaceutical

Pyramid-Shaped Crystal Pharma Deal Toy

Pyramid-shaped deal toy marking the acquisition of Focus Consumer Healthcare. Chattanooga, Tennessee-based Focus sells supplements and OTC medicines. (23AZH204)

2 Images
Back view of pyramid-shaped crystal commemorating a pharmaceutical acquisition.

Stethoscope-Themed Crystal Deal Tombstone

Custom crystal deal tombstone recognizing the acquisition of DiagnosTEX. The Texas-based company provides onsite dysphagia imaging. (24ALJ193)

1 Image

First-in-Human Dose Commemorative for Asthma Treatment

Custom Lucite commemorative recognizing the first-in-human dose of a treatment for inflammatory lung diseases. (22ALJ326)

1 Image

Home-Based Care Provider Deal Toy

Logo-themed crystal deal toy recognizing the recapitalization of Texas-based home health provider Frontpoint. (22AKL052)

1 Image

Deal Tombstone with Crystal Pills

Custom deal tombstone, featuring a crystal desktop monitor and pills on a base, marking the acquisition of Paciv. The company specializes in process automotion for regulatory compliance in the biotech, pharmaceutical, and medical device sectors. (23AKL327)

2 Images
Side view of deal tombstone featuring crystal pills marking the acquisition of systems integration firm Paciv.

Laboratory Beaker Deal Tombstone

Crystal deal tombstone commemorating the acquisition by Quest Diagnostics of Lifelabs, the Canadian laboratory testing company. (24AKL491)

1 Image

Brain-Themed Crystal Deal Tombstone

Crystal deal tombstone, featuring a cutout of a human brain, marking a follow-on offering by NeuroOne Meidcal Technologies. The Minnesota-based company’s technology targets patients suffering from neurological disorders. (25AKL138)

1 Image

Vitamin Jar-Themed Financial Tombstone

Crystal financial tombstone marking the acquisition of Adapted Nutrition, which specializes in the keto supplements market. (21ALJ612)

1 Image

Adrenal Drug FDA Approval Lucite

Custom Lucite celebrating the approval by the U.S. Food and Drug Administration (FDA) of the drug Crenessity. Crenessity was developed by Neurocrine Biosciences to treat a rare congenital adrenal condition. (25ALJ020)

1 Image